Caspase activation, inhibition, and reactivation: A mechanistic view

Caspases, a unique family of cysteine proteases, execute programmed cell death (apoptosis). Caspases exist as inactive zymogens in cells and undergo a cascade of catalytic activation at the onset of apoptosis. The activated caspases are subject to inhibition by the inhibitor‐of‐apoptosis (IAP) famil...

Full description

Saved in:
Bibliographic Details
Published inProtein science Vol. 13; no. 8; pp. 1979 - 1987
Main Author Shi, Yigong
Format Journal Article
LanguageEnglish
Published Bristol Cold Spring Harbor Laboratory Press 01.08.2004
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Caspases, a unique family of cysteine proteases, execute programmed cell death (apoptosis). Caspases exist as inactive zymogens in cells and undergo a cascade of catalytic activation at the onset of apoptosis. The activated caspases are subject to inhibition by the inhibitor‐of‐apoptosis (IAP) family of proteins. This inhibition can be effectively removed by diverse proteins that share an IAP‐binding tetrapeptide motif. Recent structural and biochemical studies have revealed the underlying molecular mechanisms for these processes in mammals and in Drosophila. This paper reviews these latest advances.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
Article and publication are at http://www.proteinscience.org/cgi/doi/10.1110/ps.04789804.
Reprint requests to: Yigong Shi, Department of Molecular Biology, Lewis Thomas Laboratory, Princeton University, Princeton, NJ 08544, USA; e-mail: yshi@molbio.princeton.edu; fax: (609) 258-6730.
ISSN:0961-8368
1469-896X
DOI:10.1110/ps.04789804